BRCA1 and cancer: Our findings are consistent with prior studies showing higher RS results in patients with PVs in BRCA1/2 [9–15]; however, this is the first study to compare the single-gene expression of the cancer genes within the assay between patients with PVs in BRCA1/2 and the general 21-gene-tested populations.